• False Claims Act

    U.S. Supreme Court Upholds Theory of False Claims Act Liability

    U.S. Supreme Court Upholds Theory of False Claims Act Liability Practice Area / INDUSTRY: White collar litigation and government investigations; healthcare; corporate compliance The U.S. Supreme Court ruled June 16, that corporations can face False Claims Act liability if they bill a federal payor while out of compliance with regulations…

    Read More
    6 796
  • Is Your Pharmacy HIPAA Strong?

    Is Your Pharmacy HIPAA Strong? Healthcare data breaches have become so common, they hardly make a blip in the daily news cycle. We mostly think of data breaches as those impacting large healthcare systems such as hospitals or health insurers however, the majority of breaches occur in considerably smaller organizations.…

    Read More
    5 1039
  • FisherBroyles

    HIPAA 2016 Audits Phase 2: Pharmacies and Business Associates Take Notice

    HIPAA 2016 Audits Phase 2: Pharmacies and Business Associates Take Notice As part of its continued effort to assess compliance with the HIPAA Privacy, Security and Breach Notification Rules, the U.S. Department of Health & Human Services (“HHS”) Office for Civil Rights (“OCR”) announced on March 21 that it has…

    Read More
    2 704
  • Fisher Broyles

    Government Investigations: Specialty and Compounding Pharmacies Still In the Crosshairs

    Government Investigations: Specialty and Compounding Pharmacies Still In the Crosshairs Lately it seems that the specialty and compounding pharmacy industry has been under seize by federal agencies investigating alleged false claims violations. Criminal and civil investigations by the Health & Human Services Office of the Inspector General (HHS-OIG) and the…

    Read More
    2 4066
  • Federal Reserve

    Big Pharma and the Federal Reserve System

    The Connection between Big Pharma and the Federal Reserve System A few weeks into 2015, Senator Elizabeth Warren waged war on Big Pharma. The senior Massachusetts senator proposed that the pharmaceutical industry pay more for federal research. Senator Warren said that big-name drug companies have become “wealthy beyond imagination” through…

    Read More
    3 1328
  • Biotech

    Federal Reserve Threatens the Biotech Frenzy

    Federal Reserve Threatens the Biotech Frenzy   Biotech and pharmaceutical companies were engaged in mergers and acquisitions at a high level in 2014. According to date from Jefferies, 45 transactions from that year alone totaled $141 billion which is the highest on record.   The arrival of 2015 also saw…

    Read More
    4 704
  • Financial Pharmacist

    Achieving Financial Independence…Do You Know Your Number?

    Achieving Financial Independence…Do You Know Your Number? By: Timothy R. Ulbrich, Pharm.D., R.Ph. www.yourfinancialpharmacist.com   For the purpose of this article, let’s define financial independence as “the point at which one is able to make the choice as to whether or not he/she will continue to work while having great…

    Read More
    1 818
  • 4 Major Trends Driving Layoffs in Biotech and Pharma

    It may seem like the pharmaceutical industry will never experience downsizing and restructuring, what with medications and medical equipment often highly in demand, but job cuts are happening all over the place. It didn’t even spare giant drug distributor McKesson Corp, with 1,600 job cuts in its US workforce. The…

    Read More
    1 2361
  • Can Talcum Powder Really Cause Cancer?

    Johnson & Johnson has been accused by more than 1,000 women for covering up a cancer risk. And earlier this year, the company was ordered by the St. Louis jury to pay $72 million in total damages – $62 million in punitive damages and $10 million in compensatory damages, to…

    Read More
    2 614
  • HHS Reopens Comments on Penalty Rule for Pharmaceutical Manufactures

    The Department of Health and Human Services (HHS) and the Health Resources and Services Administration (HRSA) have reopened the comment period on proposed rulemaking 340B Drug Pricing Program. For 30 days, HHS is inviting the public to comment on three areas of rulemaking: new drug price estimation, the ceiling price…

    Read More
    2 609